Magnetoencephalography as a putative biomarker for Alzheimer's disease.

Zamrini, Edward and Pekkonen, Eero and Maestú, Fernando and Funke, Michael and Makela, Jyrki and Myles, Riley and Bajo Breton, Ricardo and Sudre, Gustavo and Fernández, Alberto and Perales Castellanos, Nazareth and Pozo Guerrero, Francisco del and Stam, C.J. and Van Dijk, Bob W. and Bagic, Anto and Becker, James T. (2011). Magnetoencephalography as a putative biomarker for Alzheimer's disease.. "International Journal of Alzheimer's Disease" (n. 2011); pp. 280-289. ISSN 2090-0252. https://doi.org/10.4061/2011/280289.

Description

Title: Magnetoencephalography as a putative biomarker for Alzheimer's disease.
Author/s:
  • Zamrini, Edward
  • Pekkonen, Eero
  • Maestú, Fernando
  • Funke, Michael
  • Makela, Jyrki
  • Myles, Riley
  • Bajo Breton, Ricardo
  • Sudre, Gustavo
  • Fernández, Alberto
  • Perales Castellanos, Nazareth
  • Pozo Guerrero, Francisco del
  • Stam, C.J.
  • Van Dijk, Bob W.
  • Bagic, Anto
  • Becker, James T.
Item Type: Article
Título de Revista/Publicación: International Journal of Alzheimer's Disease
Date: April 2011
ISSN: 2090-0252
Subjects:
Faculty: E.T.S.I. Telecomunicación (UPM)
Department: Tecnología Fotónica [hasta 2014]
Creative Commons Licenses: Recognition - No derivative works - Non commercial

Full text

[img]
Preview
PDF - Requires a PDF viewer, such as GSview, Xpdf or Adobe Acrobat Reader
Download (695kB) | Preview

Abstract

Alzheimer’s Disease (AD) is the most common dementia in the elderly and is estimated to affect tens of millions of people worldwide. AD is believed to have a prodromal stage lasting ten or more years. While amyloid deposits, tau filaments, and loss of brain cells are characteristics of the disease, the loss of dendritic spines and of synapses predate such changes. Popular preclinical detection strategies mainly involve cerebrospinal fluid biomarkers, magnetic resonance imaging, metabolic PET scans, and amyloid imaging. One strategy missing from this list involves neurophysiological measures, which might be more sensitive to detect alterations in brain function. The Magnetoencephalography International Consortium of Alzheimer’s Disease arose out of the need to advance the use of Magnetoencephalography (MEG), as a tool in AD and pre-AD research. This paper presents a framework for using MEG in dementia research, and for short-term research priorities

More information

Item ID: 12146
DC Identifier: http://oa.upm.es/12146/
OAI Identifier: oai:oa.upm.es:12146
DOI: 10.4061/2011/280289
Official URL: http://www.hindawi.com/journals/ijad/2011/280289/
Deposited by: Memoria Investigacion
Deposited on: 10 Sep 2012 09:36
Last Modified: 21 Apr 2016 11:20
  • Logo InvestigaM (UPM)
  • Logo GEOUP4
  • Logo Open Access
  • Open Access
  • Logo Sherpa/Romeo
    Check whether the anglo-saxon journal in which you have published an article allows you to also publish it under open access.
  • Logo Dulcinea
    Check whether the spanish journal in which you have published an article allows you to also publish it under open access.
  • Logo de Recolecta
  • Logo del Observatorio I+D+i UPM
  • Logo de OpenCourseWare UPM